FILANA THERAPEUTICS, INC. Income Statement
FLNA|5 years of annual SEC 10-K data (FY2011-FY2015)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 5 fiscal years. All figures from audited SEC 10-K filings.
FILANA THERAPEUTICS, INC. reported $41M in revenue and $32M in net income for FY2015. Revenue has grown at a 18.9% compound annual rate over the past 4 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 3.76 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|
| Revenue | $41.1M | $10.9M | $11.5M | $16.8M | $20.6M |
| SG&A Expense | $4.8M | $7.2M | $6.7M | $14.8M | $6.3M |
| R&D Expense | $4.9M | $7.6M | $8.3M | $15.7M | $21.1M |
| Operating Income | $31.4M | -$3.9M | -$3.5M | -$13.7M | -$6.8M |
| Income Tax | -$73.0K | -$73.0K | $0 | - | -$1.5M |
| Net Income | $31.5M | -$3.4M | -$2.6M | -$12.0M | -$3.5M |
| EPS (Basic) | $0.70 | -$0.08 | -$0.06 | - | - |
| EPS (Diluted) | $0.70 | -$0.08 | -$0.06 | -$0.28 | -$0.08 |
| Shares Outstanding | 45.8M | 45.5M | 45.3M | 44.7M | 42.9M |
| Operating Margin | 76.3% | -35.8% | -30.6% | -81.5% | -32.9% |
| Profit Margin | 76.7% | -31.6% | -22.8% | -71.5% | -16.9% |